Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Apr 28, 2021 6:54pm

100 Views

Post# 33087965

todays trades

House Positions for C:VXL from 20210428 to 20210428

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
7 TD Sec	197,187	23,541	0.119	87,653	10,383	0.118	109,534	-13,158
9 BMO Nesbitt	23,000	2,760	0.12	0			23,000	-2,760
124 Questrade	12,500	1,500	0.12	250	30	0.12	12,250	-1,470
19 Desjardins	10,200	1,224	0.12	2,000	240	0.12	8,200	-984
89 Raymond James	1,703	206	0.121	0			1,703	-206
68 Leede	1,168	137	0.117	1,488	181	0.122	-320	44
33 Canaccord	0			333	39	0.117	-333	39
80 National Bank	90,336	10,763	0.119	91,299	10,885	0.119	-963	122
1 Anonymous	119,400	14,243	0.119	124,000	14,880	0.12	-4,600	637
2 RBC	1,000	115	0.115	15,410	1,845	0.12	-14,410	1,730
85 Scotia	4,101	488	0.119	23,500	2,735	0.116	-19,399	2,247
79 CIBC	17,338	2,080	0.12	132,000	15,840	0.12	-114,662	13,760
TOTAL	477,933	57,057	0.119	477,933	57,058	0.119	0	1